A subtype prediction score for primary aldosteronism.

Area of Science:

• Endocrinology
• Hypertension Research
• Diagnostic Tool Development

Background:

• Primary aldosteronism (PA) is the leading cause of endocrine hypertension.
• Adrenal venous sampling (AVS) is the gold standard for PA subtype classification but has limited availability.
• Accurate subtype diagnosis is crucial for appropriate treatment, often involving surgery.

Purpose of the Study:

• To develop and validate a clinical scoring system for predicting PA subtypes (unilateral vs. bilateral).
• To identify patients who would benefit most from undergoing AVS.
• To improve the diagnostic workflow for primary aldosteronism.

Main Methods:

• Development of a subtype prediction score using clinical characteristics from 71 PA patients.
• Multivariable logistic regression analysis to identify predictive variables.
• Receiver operating characteristic (ROC) curve analysis to evaluate the score's diagnostic accuracy.

Main Results:

• The prediction score incorporates serum potassium, plasma aldosterone concentration, and aldosterone-to-renin ratio.
• A score of 5 demonstrated 75% sensitivity and 95% specificity for differentiating PA subtypes.
• A score of 3 showed 97% sensitivity and 59% specificity.
• The ROC curve analysis yielded an area under the curve of 0.920, indicating strong discriminatory power.

Conclusions:

• The developed subtype prediction score effectively discriminates between unilateral and bilateral PA.
• This score is valuable for selecting patients who require AVS prior to surgical intervention.
• The scoring system offers a practical approach to managing PA diagnosis in resource-limited settings.